A multinational, multicenter, single visit, exploratory pharmacogenetic trial and long-term follow-up of the PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) trial - PRISMS-15

• Conditions: Multiple Sclerosis; MedDRA version: 12.0Level: PTClassification code 10028245Term: Multiple sclerosis

• Registration Number: EUCTR2009-015502-19-GB
• Lead Sponsor: Merck Serono SA – Geneva

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-03-17
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

For inclusion in the trial, all of the following inclusion criteria must be fulfilled:
1. Was randomized in the PRISMS study
2. Is willing and able to comply with the protocol
3. Written informed consent given before any trial-related activities are carried out

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Subjects are not eligible for this trial if they fulfill any of the following exclusion criteria:
1. Is unwilling or unable to participate in the study.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified